Quotient Clinical has announced that CEO Mark Egerton has received the EY Entrepreneur of the Year® 2015 Award in the healthcare category for the Midlands region.
The award recognizes outstanding entrepreneurs who demonstrate excellence and extraordinary success in areas, such as innovation, financial performance and personal commitment to their businesses and communities. Dr Egerton was selected as the Midlands winner by an independent panel of judges and received his award at a special awards dinner held at Birmingham Town Hall on 16 June, 2015. All category winners will go on to represent the Midlands at the UK finals which takes place in October, 2015. Later in the year, a global winner will be chosen from among 145 cities and 60 countries.
Dr Egerton commented: “I am delighted that Quotient Clinical has been recognized for the high level of success that we have achieved in recent years. We have surpassed all expectations for growth, enabling us to significantly increase our operating capacity. This award acknowledges all of the hard work and dedication from everyone within the company. Thanks to an incredible team, we have repeatedly demonstrated that Translational Pharmaceutics® can deliver significant time and cost savings for our customers, helping them to increase their overall R&D productivity.”